|
IWS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.365600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.624370E-01 |
| Normal-vs-Stage2 |
1.812610E-01 |
| Normal-vs-Stage3 |
4.175000E-01 |
| Normal-vs-Stage4 |
4.104600E-01 |
| Stage1-vs-Stage2 |
7.365200E-01 |
| Stage1-vs-Stage3 |
6.915800E-02 |
| Stage1-vs-Stage4 |
9.905500E-02 |
| Stage2-vs-Stage3 |
1.234020E-01 |
| Stage2-vs-Stage4 |
1.151600E-01 |
| Stage3-vs-Stage4 |
7.229000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.835200E-01 |
| Normal-vs-AfricanAmerican |
7.420800E-01 |
| Normal-vs-Asian |
3.568600E-01 |
| Caucasian-vs-AfricanAmerican |
7.076200E-01 |
| Caucasian-vs-Asian |
6.387900E-02 |
| AfricanAmerican-vs-Asian |
1.128790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.006300E-02 |
| Normal-vs-Female |
6.134400E-02 |
| Male-vs-Female |
1.008650E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.838800E-01 |
| Normal-vs-Extreme_Weight |
5.894000E-02 |
| Normal-vs-Obese |
7.983000E-01 |
| Normal-vs-Extreme_Obese |
8.857400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.666000E-01 |
| Normal_Weight-vs-Obese |
2.189200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.094400E-01 |
| Extreme_Weight-vs-Obese |
4.474300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.941000E-01 |
| Obese-vs-Extreme_Obese |
7.641400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.911780E-02 |
| Normal-vs-Age(41-60Yrs) |
6.651200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.697800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.273240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.863700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.994240E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.403900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.246490E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.668100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.543400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.340600E-01 |
| Normal-VS-Type2 PRCC |
2.061000E-01 |
| Normal-VS-KIRP CIMP |
7.855400E-03 |
| Normal-VS-Unclassified PRCC |
9.217000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.409800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.984270E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.563400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.444420E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.998600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.742800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.490460E-02 |
| Normal-vs-N1 |
2.100500E-02 |
| Normal-vs-N2 |
1.740230E-01 |
| N0-vs-N1 |
6.775500E-04 |
| N0-vs-N2 |
4.219800E-02 |
| N1-vs-N2 |
7.209200E-01 |
|
|
